【结 构 式】 |
【药物名称】Nexavar;Sorafenib Tosylate 【化学名称】4-[4-[3-[4-Chloro-3-(trifluoromethyl) phenyl]ureido]phenoxy]-N2-methylpyridine-2-carboxamide 4-methylbenzensulfonate 【CA登记号】475207-59-1 【 分 子 式 】C21H16ClF3N4O3.C7H6O3S 【 分 子 量 】637.03 |
【开发单位】Bayer Pharmceuticals Corp. 【药理作用】Anti tumor |
合成路线1
【1】 Wilhelm S. 2007. Use of sorafenib for the treatment of cancers having resisunce to chemotherapeutic agents. W0 2007059155 |
【2】 Bankston D, Dumas J, Natero R, et al. 2002. A scaleable synthesis of BAY 43-9006: a potent raf kinase inhibitor for the treatment of cancer. Org Proc Dev, 6(6):777~781 |
【3】 Logers M, Gehring R, Kuhn O, et al. 2006. Process for the preparation of 4-[4-[[[[4-chloro-3-(trifluoromethyl) phenyl]amino]carbonyl]amino]phenoxy]-N-methylpyridine-2-carboxamide and its tosylate salt. WO 2006034796 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 29950 | 2-pyridinecarboxylic acid;picolinic acid;Pyridine-2-carboxylic acid | 98-98-6 | C6H5NO2 | 详情 | 详情 |
(II) | 49908 | 4-chloropyridine-2-carbonyl chloride hydrochloride;(4-Chloro-2-pyridinecarbonyl Chloride Hydrochloride);4-Chloro-2-pyridinecarbonyl Chloride Hydrochlorid | 51727-15-2 | C6H3Cl2NO.HCl | 详情 | 详情 |
(III) | 49910 | 4-chloro-N-methyl-2-pyridinecarboxamide;4-chloro-N-methylpyridine-2-carboxamide;4-chloro-N-methylpicolinamide;4-Chloro-N-methylpicolinamide;2-(N-Methylcarbamoyl)-4-chloropyridine;4-Chloropyridine-2-carboxylicacid methylamide;N-Methyl-4-chloro-2-pyridinecarboxamide;N-Methyl-4-chloropicolinamide | 220000-87-3 | C7H7ClN2O | 详情 | 详情 |
(IV) | 15715 | 4-Aminophenol | 123-30-8 | C6H7NO | 详情 | 详情 |
(V) | 49912 | 4-(4-aminophenoxy)-N-methyl-2-pyridinecarboxamide | 284462-37-9 | C13H13N3O2 | 详情 | 详情 |
(VI) | 37868 | 1-chloro-4-isocyanato-2-(trifluoromethyl)benzene; 4-chloro-3-(trifluoromethyl)phenyl isocyanate | 327-78-6 | C8H3ClF3NO | 详情 | 详情 |
(VII) | 66747 | 4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-N-methylpyridine-2-carboxamide | 284461-73-0 | C21H16ClF3N4O3 | 详情 | 详情 |
合成路线2
【1】 Wilhelm S. 2007. Use of sorafenib for the treatment of cancers having resisunce to chemotherapeutic agents. W0 2007059155 |
【2】 Bankston D, Dumas J, Natero R, et al. 2002. A scaleable synthesis of BAY 43-9006: a potent raf kinase inhibitor for the treatment of cancer. Org Proc Dev, 6(6):777~781 |
【3】 Logers M, Gehring R, Kuhn O, et al. 2006. Process for the preparation of 4-[4-[[[[4-chloro-3-(trifluoromethyl) phenyl]amino]carbonyl]amino]phenoxy]-N-methylpyridine-2-carboxamide and its tosylate salt. WO 2006034796 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 51494 | 4-Chloro-3-trifluoromethylaniline; 4-Chloro-alpha,alpha,alpha-trifluoro-m-toluidine; 5-Amino-2-chlorobenzotrifluoride; 2-Chloro-5-aminobenzotrifluoride; 2-Amino-5-chlorotrifluoromethylbenzene | 320-51-4 | C7H5ClF3N | 详情 | 详情 |
(II) | 11353 | 1,1'-Carbonyldiimidazole; Di(1H-imidazol-1-yl)methanone; N,N-Carbonyldiimidazole; 1,1'-Carbonylbis(1H-imidazole) | 530-62-1 | C7H6N4O | 详情 | 详情 |
(III) | 49912 | 4-(4-aminophenoxy)-N-methyl-2-pyridinecarboxamide | 284462-37-9 | C13H13N3O2 | 详情 | 详情 |
(IV) | 66747 | 4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-N-methylpyridine-2-carboxamide | 284461-73-0 | C21H16ClF3N4O3 | 详情 | 详情 |
Extended Information